Saudi Pharma in Talks With Germany’s CureVac for Covid Shot - (Bloomberg via NewsPoints Desk)

  • Saudi Pharmaceutical Industries and Medical Appliances has signed a non-binding memorandum of understanding with CureVac to provide a COVID-19 vaccine in Saudi Arabia, reported Bloomberg.

  • Saudi Pharma said the availability of the vaccine is subject to approval from the kingdom’s Ministry of Health and Food and Drug Authority.

  • The agreement includes the possibility of extending the supply and distribution rights in the United Arab Emirates, Kuwait, Bahrain, and Oman.

  • CureVac’s COVID-19 vaccine candidate showed a good immune response in early trials and its chief executive officer said advanced clinical trials are on track to start by the end of the year. 

  • The European Union has agreed to pay $11.84 per dose for an initial supply of 225 million doses of CureVac’s vaccine.

To read more NewsPoints articles, click here.